Editorial comment to suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Shizuo
S
Yamada
D000818:Animals; D050197:Atherosclerosis / Q000150:complications; D004338:Drug Combinations; D004979:Ethamsylate / Q000494:pharmacology* / Q000627:therapeutic use*; D007511:Ischemia / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D010936:Plant Extracts / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D001743:Urinary Bladder / Q000098:blood supply*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D004338:Drug Combinations; D010936:Plant Extracts; D004979:Ethamsylate; C010152:eviprostat